six-month period ended June 30, 2019. The period-on-period increase in finance costs was because of a loan withdrawal to construction disbursement and purchasing medical equipment. Net profits The
interest expense. The subsidiary paid off loan from bank in 2017 and borrowed at the end of 1Q’18. Net Profits The Company’s 1Q’18 consolidated net profit before deduction of non-controlling interest (NCI
September 30, 2018 and Baht 7.87 million in the nine-month period ended September 30, 2019. The period-on-period increase in finance costs was because of a loan withdrawal to construction disbursement and
mainly to employee expenses and repair and maintenance of premises and equipment expenses, whereas marketing expenses fell. As a result, our cost- to-income ratio stood at 42.70 percent, which was still
received 23 Short-term loan to related parties decrease (increase) 94 Purchase of property, plant and equipment (2) Purchase of intangible assets (112) Net cash from (used in) investing activities 3 Cash
decrease of Bt11.3 million or 2.9%(y-o-y), mainly were the decreased in personnel expenses, the consulting fee, the expenditure on computers and equipment and general administrative expenses. The Cost of
equipment for lease 118.9 141.0 (22.1) (15.7) Cost of Sales and Service 5,882.8 3,301.1 2,581.7 78.2 Cost of equipment for lease 59.1 89.4 (30.3) (33.9) Selling Expenses 215.3 185.0 30.3 16.4 Administrative
combined net profit of the commercial banking system was Baht 187.3 billion, a 5.7 percent decrease from last year, due to larger loan impairment charges set aside for credit losses in compliance with IFRS9
. (6) Financial cost The Company and its subsidiaries’ financial cost from loan and permission note were Baht 18.07 million or increased from the same period of previous year by Baht 9.97 million or
, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of